| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SCLX sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 244.45M | $131.85M | - | |
| 10% | 958.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Scilex Holding Co75 | 10% Owner | Sell | 20,657,300 | $0.62 | $12,771,579.75 | -7.8% | -48.5% | - | |
| Dec 18, 2024 | Shah Jaisim | See Remarks | Buy | 30,000 | $0.46 | $13,800.00 | +27.4% | -32.7% | -9.1% | |
| Oct 31, 2024 | Ji Henry | Executive Chairperson | Buy | 8,888 | $0.94 | $8,351.16 | +2.9% | -53.1% | -50.9% | |
| Oct 29, 2024 | Shah Jaisim | See Remarks | Buy | 32,000 | $0.99 | $31,670.40 | +41.4% | -53.8% | -47.0% | |
| Oct 18, 2024 | Followwill Dorman | Director | Buy | 1,000 | $0.99 | $990.00 | +76.9% | -51.6% | -62.4% | |
| Oct 18, 2024 | Chun Jay | Director | Buy | 5,000 | $0.95 | $4,750.00 | +4.7% | -51.6% | -62.4% | |
| Oct 17, 2024 | Lemus David | Director | Buy | 2,000 | $0.90 | $1,800.00 | New | -52.9% | -61.4% | |
| Oct 17, 2024 | Wu Yue Alexander | Director | Buy | 20,000 | $0.95 | $18,992.00 | +400.0% | -52.9% | -61.4% | |
| Oct 17, 2024 | Ji Henry | Executive Chairperson | Buy | 10,000 | $0.97 | $9,710.00 | +20.0% | -52.9% | -61.4% | |
| Oct 16, 2024 | Ma Stephen Hoi | Chief Financial Officer | Buy | 6,700 | $0.97 | $6,499.00 | +41.5% | -48.3% | -56.3% |